|
| | Issue Date | Title | Author(s) |
| 1 | Sep-2010 | Artificial hydration at the end of life in an oncology ward in Singapore | Krishna, L.K.; Poulose, J.; Goh, C. |
| 2 | 1991 | Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin) | Goh, C.R. ; Loh, C.-S. ; Porter, A.G. |
| 3 | Jun-2011 | Attitude of doctors in an asian oncology centre towards referral to palliative care | Hong, C.-Y.; Ng, G.N.; Poulose, J.; Lin, N.J.; Goh, C.R. |
| 4 | 1989 | Bacterial expression, facile purification and properties of recombinant human lymphotoxin (tumor necrosis factor beta) | Seow, H.-F. ; Goh, C.R. ; Krishnan, L.; Porter, A.G. |
| 5 | Mar-1990 | c-myc Oncogene expression in colorectal cancer: its use in prognosis and role in colorectal carcinogenesis. | Goh, H.S.; Soong, T.W. ; Lee, Y.S.; Ho, J.; Goh, C.R. |
| 6 | Jul-1987 | Clinico-pathological prognostic factors of large bowel cancer in Singapore: a multivariate analysis. | Goh, H.S.; Goh, C.R. ; Rauff, A.; Foong, W.C. |
| 7 | Jul-2013 | Exploring the experience of dignified palliative care in patients with advanced cancer and families: A feasibility study in Singapore | Lee, G.L. ; Ow, R. ; Akhileswaran, R.; Goh, C.R. |
| 8 | Jul-1993 | Galloway Memorial Lecture. Protein engineering of tumor necrosis factor-beta and its applications in cancer, septicaemia and cachexia. | Goh, C.R. |
| 9 | Aug-2012 | Good end-of-life care: Perspectives of middle-aged and older Singaporeans | Malhotra, C. ; Chan, A.; Do, Y.K.; Malhotra, R. ; Goh, C. |
| 10 | 15-May-1993 | Identification of a new receptor subtype for tumor necrosis factor-α | Schwalb, D.M.; Han, H.-M.; Marino, M.; Warren, R.; Porter, A. ; Goh, C. ; Fairt, W.R.; Donner, D.B. |
| 11 | May-1991 | Influence of family history of cryptogenic hypertension, age, sex and race on lymphocyte sodium/potassium pumps. | Taylor, E.A.; Goh, C.R. ; Oh, V.M. |
| 12 | Oct-2010 | Opioid use amongst cancer patients at the end of life | Radha Krishna, L.K.; Poulose, J.V.; Tan, B.S.A.; Goh, C. |
| 13 | 1-Oct-2011 | Place of death and its determinants for patients with cancer in Singapore: An analysis of data from the Singapore cancer registry, 2000-2009 | Hong, C.Y.; Chow, K.Y.; Poulose, J.; Jin, A.Z.; Devi, A.; Chee, E.M.F.; Goh, C. |
| 14 | 1992 | Recombinant human tumor necrosis factor-β entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro | Tan, L.; Goh, C.R. ; Porter, A.G. |
| 15 | 2010 | Risk communication in clinical trials: A cognitive experiment and a survey | Cheung, Y.B. ; Wee, H.L. ; Thumboo, J.; Goh, C. ; Pietrobon, R. ; Toh, H.C.; Yong, Y.F. ; Tan, S.B. |
| 16 | 1991 | Structural and functional domains in human tumour necrosis factors | Goh, C.R. ; Porter, A.G. |
| 17 | 1-Aug-1997 | The lymphotoxin-α (LTα) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTα1β2 heterotrimeric ligand | Williams-Abbott, L.; Walter, B.N.; Cheung, T.C.; Goh, C.R. ; Porter, A.G. ; Ware, C.F. |
| 18 | 1990 | Tumour necrosis factors in clinical practice | Goh, C.R. |
| 19 | Feb-2011 | What do renal health-care professionals in Singapore think of advance care planning for patients with end-stage renal disease? | Yee, A.; Seow, Y.Y.; Tan, S.H.; Goh, C. ; Qu, L.; Lee, G. |
| 20 | Aug-2009 | Where the elderly die: The influence of socio-demographic factors and cause of death on people dying at home | Beng, A.K.L.; Chee, W.F.; Shum, E.; Goh, C.R. ; Kee, T.G.; Suok, K.C. |
